Eurofins Scientific

Eurofins Scientific is an international group of life sciences companies that provides a wide range of analytical testing services to clients across multiple industries. The group considers itself a global leader in food, environment, pharmaceutical and cosmetic product testing, discovery pharmacology, forensics, advanced material sciences, and agroscience Contract Research services. It is also among the global independent market leaders in genomics and clinical study support, BioPharma Contract Development and Manufacturing, and is an emerging player in esoteric and molecular clinical diagnostic testing.

Founded in 1987 by Gilles Martin, Eurofins is headquartered in Luxembourg City, Luxembourg. It is publicly traded (Euronext Paris: ERF) and a component of the CAC 40 index, with Gilles Martin serving as chairman and CEO. In its first decade the company marketed its SNIF-NMR technology, using Nuclear Magnetic Resonance to detect added sugar and monitor alcohol content in wine.

The group operates at significant scale, with over 65,000 staff across a network of more than 1,000 independent companies in 59 countries and over 950 laboratories. It offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products. Services span forensic, genomic, maritime, materials and engineering, REACH, consumer product, cosmetics and personal care, environment (water, air, soil, waste), and food and feed testing.

Reported revenue was €6.951 billion (2024), with operating income of €529.9 million and net income of €310.2 million (2023), and roughly 63,000 employees (2024). Given the company's reliance on a vast range of analytical methods and laboratory operations, innovations in testing technology, automation, and diagnostics are directly relevant to its core business.